The continuous and semi-continuous bioprocessing market The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-continuous manufacturing capabilities for biointensification London Roots Analysis has announced the addition of “Continuous and Semi-Continuous Bioprocessing Market, 2021 – 2030” report to its list of offerings. Given the growing pipeline of biological drugs, and the rising preference for such therapeutic interventions, the demand for cost-effective biomanufacturing processes has increased. As a result, several innovators and contract service providers are evaluating the potential of continuous and semi-continuous upstream and downstream bioprocessing technologies, owing to their various advantages. To order this 190+ page report, which features 60+ figures and 115+ tables, please visit this https://www.rootsanalysis.com/reports/continuous-and-semi-continuous-bioprocessing-market.html Key Market Insights Presently, more than 70 companies claim to have capabilities for continuous manufacturing of biologics Close to 45% of the continuous and semi-continuous bioprocessing companies are headquartered in Europe; further, around 20% of these companies have established their dedicated facilities in other geographical regions, such as North America and Asia-Pacific. Over 65% of the installed continuous upstream manufacturing capacity belongs to established players More than 40% of the global continuous upstream processing capacity is installed in Europe, followed by Asia-Pacific (33%). Further, close to 55% of the capacity belongs to the facilities owned by contract service providers. Continuous and semi-continuous bio-intensification approach has potential to save ~40% of the overall biopharmaceutical manufacturing cost By 2030, we expect that adoption of continuous and semi-continuous approach is likely to enable the net, annual cost savings of close to USD 50 billion. By 2030, the opportunity within the continuous and semi-continuous bioprocessing market is likely to be over USD 500 million Presently, the use of continuous and semi-continuous bio-intensification approach is largely restricted to the developed nations, and the majority of revenues from biologics manufactured via this approach are distributed between North America (~25%) and Europe (~40%). Once this process is adopted for the end-to-end manufacturing of biologics, estimates in the report suggest are likely to grow at even higher pace. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/continuous-and-semi-continuous-bioprocessing-market.html Key Questions Answered  Who are the leading contract manufacturers with expertise in continuous and semi-continuous bioprocessing?  Who are the leading innovators / drug developers with expertise in continuous and semi-continuous bioprocessing?  In which regions are majority of the continuous and semi-continuous bioprocessing facilities located?  What is the likely cost saving potential of continuous and semi-continuous bioprocessing technology?  What is the currently installed global capacity for continuous and semi-continuous bioprocessing?  How is the current and future market opportunity likely to be distributed across key market segments? The USD 500+ million (by 2030) financial opportunity associated with continuous and semi-continuous bioprocessing services market has been analyzed across the following segments:  Type of Manufacturer  Innovator / Drug Developer  Contract Service Provider  Company Size  Large  Mid-sized  Small  Scale of Operation  Preclinical / Clinical  Commercial  Stage of Bioprocess  Upstream Bioprocessing  Downstream Bioprocessing  Geographical Regions  North America  Europe  Asia-Pacific  MENA  Latin America and Rest of the World The report also features inputs from eminent industry stakeholders, according to whom, continuous and semi-continuous bioprocessing technologies are likely to witness a significant increase in the adoption rate in the near future, given their advantages over the traditional bioprocessing technologies. The report includes detailed transcripts of discussions held with the following experts:  Jon Coffman (Senior Director of Bioprocess Technology and Engineering, AstraZeneca)  Ehsan Mahdinia (Assistant Professor, Albany College of Pharmacy and Health Sciences)  Himanshu Gadgil (Director and Chief Scientific Officer, Enzene Biosciences) The research includes profiles of key players (listed below), featuring a brief overview of the company, financial information (if available), details on its service portfolio, continuous and semi-continuous bioprocessing capabilities, scale of operation, stage of bioprocess, types of biologics manufactured, continuous and semi-continuous bioprocessing manufacturing facilities, recent developments and an informed future outlook.  AGC Biologics  Biogen  Bristol-Myers Squibb  Enzene Biosciences  FUJIFLM Diosynth Biotechnologies  Merck KGaA  Novasep  Sanofi Genzyme  UCB Pharma  WuXi Biologics For additional details, please visit https://www.rootsanalysis.com/reports/continuous-and-semi-continuous-bioprocessing-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030 2. Lipid Contract Manufacturing Market: Industry Trends and Global Forecasts, 2021-2030 3. Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030 4. Vaccine Contract Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2030 Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/